Sheng-Yu Ku

12PUBLICATIONS
107CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 23, 2025
Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer.

Sheng-Yu Ku, Nishat Manzar, Maria Mica Garcia

|Oct 03, 2025
Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer.

Sheng-Yu Ku, Nishat Manzar, Maria Mica Garcia

|Jul 02, 2025
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

Kei Mizuno, Sheng-Yu Ku, Varadha Balaji Venkadakrishnan

|Aug 08, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.

Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh

|Feb 26, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.

Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh

|Jan 10, 2024
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.

Gian Marco Franceschini, Orsetta Quaini, Kei Mizuno

Pageof 2